SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes

Author:  ["Rebecca Berdeaux","Naomi Goebel","Laura Banaszynski","Hiroshi Takemori","Thomas Wandless","G Diane Shelton","Marc Montminy"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

During physical exercise, increases in motor neuron activity stimulate the expression of muscle-specific genes through the myocyte enhancer factor 2 (MEF2) family of transcription factors. Elevations in intracellular calcium increase MEF2 activity via the phosphorylation-dependent inactivation of class II histone deacetylases (HDACs). In studies to determine the role of the cAMP responsive element binding protein (CREB) in skeletal muscle, we found that mice expressing a dominant-negative CREB transgene (M-ACREB mice) exhibited a dystrophic phenotype along with reduced MEF2 activity. Class II HDAC phosphorylation was decreased in M-ACREB myofibers due to a reduction in amounts of Snf1lk (encoding salt inducible kinase, SIK1), a CREB target gene that functions as a class II HDAC kinase. Inhibiting class II HDAC activity either by viral expression of Snf1lk or by the administration of a small molecule antagonist improved the dystrophic phenotype in M-ACREB mice, pointing to an important role for the SIK1-HDAC pathway in regulating muscle function.

Cite this article

Berdeaux, R., Goebel, N., Banaszynski, L. et al. SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat Med 13, 597–603 (2007). https://doi.org/10.1038/nm1573

View full text

>> Full Text:   SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes

MicroRNA-133 controls cardiac hypertrophy

Antielastin autoimmunity in tobacco smoking–induced emphysema